University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 9 of 29

COMPLETED NA

Restaurant Menu Carbon Footprint Labeling

NCT05592340

COMPLETED NA

Planning Message Recommending Same Time/Location as Last Vaccine

NCT05612386

COMPLETED NA

Message Encouraging Vaccination in Preparation for the Holidays

NCT05612360

COMPLETED NA

Suicide Prevention Intervention for Vulnerable Emerging Adult Sexual Minorities

NCT05018143

COMPLETED NA

Pharmacogenetic-guided Choice of Post-surgery Analgesics

NCT05548660

COMPLETED NA

The Impact of Dyad Exercises on Well-being and Connection in Young Adults

NCT05490979

COMPLETED NA

De-adopting Routine Preoperative Benzodiazepines for Older Surgical Patients

NCT05436392

COMPLETED NA

Comparative Effectiveness of 7 Versus 21 Home-delivered Medically Tailored Meals to Improve Malnutrition Risk in Malnourished Patients With Heart Failure

NCT06142903

TERMINATED Phase 2

Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder

NCT04454411

TERMINATED

Resting State fMRI in Disorders of Consciousness

NCT05463029

COMPLETED Phase 4

Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

NCT05548647

COMPLETED NA

Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease

NCT05471622

COMPLETED

Way To Drive Validation Study

NCT05422586

COMPLETED NA

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers

NCT05271578

COMPLETED NA

Increasing Implementation of Post-Operative Opioid Prescribing Guidelines

NCT05358522

COMPLETED NA

Rehab CARES In USA: Clinical Trial

NCT05542121

COMPLETED NA

Neurofeedback to Treat Depression

NCT05169346

COMPLETED NA

TeamSTEPPS in School Mental Health

NCT04440228

COMPLETED NA

Functionality of the Pulse Oximeter and Accelerometer Portions of a Novel Wearable Device

NCT05197790

TERMINATED NA

rTMS Pilot for Anxiety

NCT05306977

COMPLETED NA

ProduceRx: Improving Weight and Cardiovascular Risk in Adults With Food Insecurity and Obesity

NCT05362747

COMPLETED NA

How v. How and Why Nudges and Rewards

NCT05376059

COMPLETED NA

MORE-PC: A 30-day Automated SMS Program to Support Post-discharge Transitions of Care

NCT05245773

COMPLETED NA

Message Testing for CKD

NCT05462158

COMPLETED NA

Engaging Suicidal Patients in Mental Health Treatment

NCT05021224

COMPLETED NA

Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area

NCT05167864

COMPLETED NA

Intensive TMS for Bipolar Depression

NCT05228457

COMPLETED

Early Detection of Neuropathy in ATTRv

NCT05311488

COMPLETED Phase 4

Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)

NCT04535999

COMPLETED

COVID-19 Screening Program

NCT05216627

COMPLETED Phase 2

Povidone-Iodine Oral Rinse Study

NCT05239598

COMPLETED NA

Managed Problem Solving for ART Adherence and HIV Care Retention Delivered by Community Health Workers

NCT04560621

COMPLETED NA

Public Support for COVID-19 Test Allocation

NCT05185687

TERMINATED NA

Strategies in Patients Undergoing Repeat AF Ablation

NCT05185310

COMPLETED NA

Basic Income Guaranteed: Los Angeles Economic Assistance Pilot

NCT07200648

COMPLETED Phase 4

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

NCT04434664

COMPLETED NA

Health Care Workers and Mental Health

NCT05028075

COMPLETED NA

Individualized Closed Loop TMS for Working Memory Enhancement

NCT04402294

COMPLETED NA

Nursing Attitudes Towards SUD

NCT05218681

COMPLETED NA

Mixed Presentation on Social Media

NCT05066126

COMPLETED NA

Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)

NCT05121675

COMPLETED NA

Default Genetics Referrals for Young-Onset Colorectal Cancer

NCT05018156

COMPLETED NA

Effect of a Virtually Implemented Cardiac Rehabilitation Program

NCT05201976

COMPLETED NA

Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide

NCT05260112

COMPLETED NA

The STEP 4Life Trial

NCT05069155

COMPLETED NA

CCTs to Address Social Needs in a Primary Care Clinic

NCT05201586

TERMINATED NA

Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program

NCT03229811

COMPLETED Phase 2

Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure

NCT04956809

COMPLETED NA

Personalized Patient and Caregiver Education After Stroke

NCT05118503

COMPLETED NA

Online Study of the Effects of Sugary Drink Warning Labels on Consumption

NCT05079477

← Previous Page 9 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.